Nephrology News

WASHINGTON — Acute kidney injury in association with major complications was linked with decreased survival in patients who have undergone coronary artery bypass grafting, according to data presented at ASN Kidney Week.

WASHINGTON — At ASN Kidney Week, Brad H. Rovin, MD, presented results of the NOBILITY trial, a phase 2 randomized, controlled study of obinutuzumab with mycophenolate and corticosteroids in patients with proliferative lupus nephritis.

WASHINGTON — Results from an ancillary study to the Vitamin D and Omega-3 Trial, known as VITAL, demonstrated no difference in eGFR reduction between patients with type 2 diabetes who were assigned to either supplementation or placebo. Data were presented at ASN Kidney Week and simultaneously published in JAMA.

WASHINGTON — ANG-3777, a hepatocyte growth factor mimetic, may be an effective treatment for delayed graft function in patients undergoing kidney transplant, according to study results presented at ASN Kidney Week.

WASHINGTON — Ritonavir-boosted protease inhibitors do not significantly impact creatinine-based GFR estimates compared with measured GFR for HIV-positive patients, according to data presented at ASN Kidney Week.

WASHINGTON — First-year data were presented here at ASN Kidney Week from a new registry developed to research the etiology of patients in Mexico who do not have typical links to chronic kidney disease.

Baxter International Inc. and Ayogo have released CKD&Me, an app for smartphones and tablets that tailors its educational content to the individual learning needs of patients with chronic kidney disease.

WASHINGTON — Lower hemoglobin levels may be a strong and independent predictor of higher risk of major adverse kidney events within 7 days after cardiac surgery or admittance to the ICU, according to data presented at ASN Kidney Week.

WASHINGTON — Data presented at ASN Kidney Week show Outset Medical’s Tablo hemodialysis system was safe and effective for both in-center or at-home use.

WASHINGTON — Today, HHS Secretary Alex Azar II was presented with the American Society of Nephrology’s President’s Medal, an award that recognizes individuals who, despite not being ASN members, have helped advance the society’s mission, according to ASN President Mark E. Rosenberg, MD, FASN.